Use of empagliflozin as an adjuvant treatment for obstructive sleep apnea for a patient who has not seen a physician in over 40 years
A clinical decision report using: Neeland IJ, Eliasson B, Kasai T, et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care. 2020;43(12):3007-3015. https://doi.org/10.2337/dc20-1096 for a patient with obstructive sleep apnea who has not seen a physician in over 40 years.
Authors
- А. Е. Демко (ORCID: https://orcid.org/0000-0002-5606-288X)
Publication Details
- Journal
- Clinical Research in Practice The Journal of Team Hippocrates
- Published
- 2024-11-27
- DOI
- https://doi.org/10.22237/crp/1724284980
- Primary Topic
- Obstructive Sleep Apnea Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00